Cancerous inhibitor of PP2A (CIP2A) is an oncoprotein that is well documented as being a major player in cancer, primarily by inhibiting the activity of the serine/threonine phosphatase protein phosphatase 2A (PP2A) [1]. The gene discussed is PTPA; the disease is cancer.